Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:00 PM
Ignite Modification Date:
2025-12-24 @ 2:00 PM
NCT ID:
NCT02344095
Eligibility Criteria:
Inclusion Criteria:
* Recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal carcinoma (At the first diagnosis, pathologic findings should be confirmed.)
* Response assessments that are possible by using radiologic tests or tumor markers
* The number of chemotherapeutic regimens that were previously used ≤ 2
* Adequate hematologic, hepatic, and renal functions
* ECOG performance status 0 - 2
Exclusion Criteria:
* Recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal carcinoma that are located on the part of body where it is impossible to deliver energy by using oncothermia (EHY 2000) probe
* Neurotoxicity ≥ grade 2
* Pacemaker user
* Large metal materials such as artificial joint that are kept in the body
* Recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal carcinoma that are located on the part of body where got previously radiation therapy
Healthy Volunteers:
False
Sex:
FEMALE
Study:
NCT02344095
Study Brief:
Protocol Section:
NCT02344095